Reuters logo
BRIEF-Basilea Pharmaceutica ‍announces presentation of interim phase 1/2a clinical data with anticancer drug candidate BAL101553
2017年6月6日 / 凌晨5点18分 / 4 个月前

BRIEF-Basilea Pharmaceutica ‍announces presentation of interim phase 1/2a clinical data with anticancer drug candidate BAL101553

June 6 (Reuters) - BASILEA PHARMACEUTICA AG:

* ‍ANNOUNCES PRESENTATION OF INTERIM PHASE 1/2A CLINICAL DATA WITH ANTICANCER DRUG CANDIDATE BAL101553 AT ASCO MEETING​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below